2020 has presented many challenges. But, through it all, we’ve been determined to support our employees, customers, and communities. Because of this, we are honored to be recognized by Forbes and JUST Capital in the #AmericasMostJUST and #1 spot for workers in the Pharmaceuticals and Biotech Companies. https://lnkd.in/e6Z9WqM
Well deserved from the excellent staff I know! Congratulations!
Today Illumina is acquiring Fluent BioSciences Inc. to accelerate the adoption of single-cell analysis and help customers with the broadest range of project sizes. On our mission to unlock the power of the genome to improve human health, we see this as a step to enable faster discovery. Learn more: https://bit.ly/3XYQdPk
Since its founding in 2022, iHope China has supported over 500 families with rare genetic diseases by providing free genetic testing and offering systematic training to front-line clinicians. By the end of 2024, the program aims to broaden its reach and impact—supporting 1,800 families with genetic testing. #Genomics4All #IlluminaProud Learn more about how the Illumina iHope China program is making strides to more than triple their impact: https://bit.ly/3VXa8Nb.
We are proud to have ranked #5 on the inaugural TIME's World’s Most Sustainable Companies list, highlighting the incredible work being done by employees around the globe to make our operations, supply chain, and products more sustainable, including: ✅ 53% reduction in packaging ✅ 8% decrease in water usage (YoY) ✅ 100% of global electricity consumption from renewable sources
How to implement genomics in the clinic? Illumina was joined by 12 health system leaders to discuss strategies for boosting patient engagement, reporting results, and improving health outcomes. Learn more: https://bit.ly/4cczlc9
Happy Juneteenth! Not sure how to honor this holiday? Tracey Cooper, Associate Director of DEI and Jarret Southern, CGBP, Sr. Staff Program Manager share the importance of Juneteenth and how you can celebrate. #IlluminaProud
Find answers to your boldest research questions, expand the scope of your experimental studies and get untapped insights into biological phenomena, pathways and systems with next-generation sequencing: https://bit.ly/3VGqGZP What will you use next-generation sequencing for?
We are excited to share that Illumina has been included on the U.S. News & World Report Best Companies to Work For list for the second consecutive year! Thank you to our employees for fostering an innovative, inclusive, and passionate culture that enables our customers to improve human health through the power of genomics. #IlluminaProud
48 hours. 122 experts. 260 datasets. 10 new diagnoses. We’re proud to participate in and sponsor #UndiagnosedHackathon2024 to help solve what had been previously deemed ‘unsolvable.’
The possibilities brought about by collaboration have never been more obvious to me than in the extraordinary initiative, that is the brainchild of Cederroth Helene and Mikk Cederroth of the Wilhelm Foundation. The #UndiagnosedHackathon2024 brought together over 122 experts from clinical genetics, patient advocacy through to computational biologists, AI and data experts from 28 countries to interrogate over 260 datasets - all with one purpose: to solve what had been previously deemed 'unsolveable'. I had the enormous privilege of opening the Undiagnosed Hackathon at the preliminary Tools Workshop. The work diagnosis does for people living with rare undiagnosed disease needed no introduction. Whilst receiving a diagnosis is never easy, it holds the possibility of care. Care is both a burden or responsibility, and an aspirational vision. Care holds the ability to cry out, to challenge stigma and to create new possibilities. The Undiagnosed Hackathon, was perhaps the most unified and significant act of care in the field of rare disease diagnosis that I have witnessed. Some of you know that I am also passionate about work that includes 'patients sitting at the front'. There was no moment more moving than when the local families joined us to start, yes, at the front. For the 26 families for whom new datasets were generated and the further 16 families for whom existing datasets were reanalysed, teams poured over clinical data, short read and long read whole genomes, transcriptomes, optical genome maps and in 48 hours provided ten new diagnoses (each with their own story of value), and found a further 9 possible diagnoses. Thank you to Mikk and Helene for compelling us to care. Thank you to the families and clinicians who put their hope in this venture. Thank you to the team at Nijmegen for your leadership and enthusiasm (Wendy van Zelst-Stams, Lisenka Vissers, Alexander Hoischen) and thank you to this team of extraordinary friends (old and new): Orion Buske, Alistair Ward, Drew Ellershaw, Holly Zheng Bradley, Gareth Baynam, Shahida Moosa, Elizabeth Emma Palmer, Michael Eberle, Samuel Wiafe, AIME LUMAKA, Raquel Peck, Tania Simoncelli, Shinya Yamamoto, Jennifer Gardner, Ann Nordgren, Steve Laurie, Pablo Botas, Salman Kirmani, Rocío Acuña Hidalgo and many more.
Senior HR Talent Acquisition Specialist - Contingent Workforce. Specialized in attracting top talent across various industries. Experienced in filling critical roles and contributing to company growth.
3yCongratulations!